Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07893067) titled 'Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of Moderate-to-Severe Melasma: A Randomized Comparative Study' on Oct. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Bangladesh Medical University
Condition:
Melasma (Facial Melasma)
Intervention:
Drug: Group B (Triple Combination Cream + Microneedling + Platelet-Rich Plasma)
Recruitment Status: Not recruiting
Phase: Phase 4
Date of Fir...